Back to VRTX

VERTEX PHARMACEUTICALS INC / MA Proceeds from Debt 2008-2012 | VRTX

Beta

What is VERTEX PHARMACEUTICALS INC / MA's current proceeds from debt?

VERTEX PHARMACEUTICALS INC / MA (VRTX) annual proceeds from debt for 2012 was $0, a NaN% decline from 2011. VERTEX PHARMACEUTICALS INC / MA proceeds from debt for the quarter ending September 30, 2010 was $391.6M.

What was VERTEX PHARMACEUTICALS INC / MA's proceeds from debt in 2011?

VERTEX PHARMACEUTICALS INC / MA annual proceeds from debt for 2011 was $0, a 100.00% decline from 2010.

What was VERTEX PHARMACEUTICALS INC / MA's proceeds from debt in 2010?

VERTEX PHARMACEUTICALS INC / MA annual proceeds from debt for 2010 was $391.6M, a 40.57% increase from 2008.

Proceeds from Debt History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGRN/A
FY2008
$278.6M
→
FY2012
$0
08101112
3 years selected
Proceeds from Debt History
PeriodValueChangeSource
FY2012$0-10-K
FY2011$0-100.0%10-K
FY2010$391.6M+40.6%10-K
FY2008$278.6M-10-K
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →